Publication | Closed Access

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Percutaneous Coronary InterventionEngineeringDe-novo Coronary LesionsBiomedical EngineeringMedicineBiomaterialsFirst-in-man Biosolve-i TrialMonth Results